These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37266849)

  • 1. GluN2B subunit selective N-methyl-D-aspartate receptor ligands: Democratizing recent progress to assist the development of novel neurotherapeutics.
    Ugale V; Deshmukh R; Lokwani D; Narayana Reddy P; Khadse S; Chaudhari P; Kulkarni PP
    Mol Divers; 2023 Jun; ():1-28. PubMed ID: 37266849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies.
    Ugale V; Dhote A; Narwade R; Khadse S; Reddy PN; Shirkhedkar A
    CNS Neurol Disord Drug Targets; 2021; 20(9):822-862. PubMed ID: 33687902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases.
    Ladagu AD; Olopade FE; Adejare A; Olopade JO
    Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GluN2B-containing NMDARs in the mammalian brain: pharmacology, physiology, and pathology.
    Ge Y; Wang YT
    Front Mol Neurosci; 2023; 16():1190324. PubMed ID: 37324591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([
    Fu H; Tang W; Chen Z; Belov VV; Zhang G; Shao T; Zhang X; Yu Q; Rong J; Deng X; Han W; Myers SJ; Giffenig P; Wang L; Josephson L; Shao Y; Davenport AT; Daunais JB; Papisov M; Yuan H; Li Z; Traynelis SF; Liang SH
    ACS Chem Neurosci; 2019 May; 10(5):2263-2275. PubMed ID: 30698943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
    Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
    Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agmatine preferentially antagonizes GluN2B-containing N-methyl-d-aspartate receptors in spinal cord.
    Waataja JJ; Peterson CD; Verma H; Goracke-Postle CJ; Séguéla P; Delpire E; Wilcox GL; Fairbanks CA
    J Neurophysiol; 2019 Feb; 121(2):662-671. PubMed ID: 30427758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
    Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
    Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.
    Hanson JE; Pare JF; Deng L; Smith Y; Zhou Q
    Neurobiol Dis; 2015 Feb; 74():254-62. PubMed ID: 25484285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying potential GluN2B subunit containing N-Methyl-D-aspartate receptor inhibitors: an integrative
    Singh R; Ganeshpurkar A; Kumar D; Kumar D; Kumar A; Singh SK
    J Biomol Struct Dyn; 2020 Jun; 38(9):2533-2545. PubMed ID: 31232189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of Tyrosine 1070 at the GluN2B Subunit Is Regulated by Synaptic Activity and Critical for Surface Expression of N-Methyl-D-aspartate (NMDA) Receptors.
    Lu W; Fang W; Li J; Zhang B; Yang Q; Yan X; Peng L; Ai H; Wang JJ; Liu X; Luo J; Yang W
    J Biol Chem; 2015 Sep; 290(38):22945-54. PubMed ID: 26229100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine depletion of the striatum causes a cell-type specific reorganization of GluN2B- and GluN2D-containing NMDA receptors.
    Zhang X; Chergui K
    Neuropharmacology; 2015 May; 92():108-15. PubMed ID: 25619731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDAR-Activated PP1 Dephosphorylates GluN2B to Modulate NMDAR Synaptic Content.
    Chiu AM; Wang J; Fiske MP; Hubalkova P; Barse L; Gray JA; Sanz-Clemente A
    Cell Rep; 2019 Jul; 28(2):332-341.e5. PubMed ID: 31291571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of synaptic GluN2B subunit-containing N-methyl-D-aspartate receptors: a physiological brake on CA1 neuron α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hyperexcitability during benzodiazepine withdrawal.
    Shen G; Tietz EI
    J Pharmacol Exp Ther; 2011 Jan; 336(1):265-73. PubMed ID: 20935233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders.
    Egunlusi AO; Joubert J
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Development of
    Ahmed H; Wallimann R; Haider A; Hosseini V; Gruber S; Robledo M; Nguyen TAN; Herde AM; Iten I; Keller C; Vogel V; Schibli R; Wünsch B; Mu L; Ametamey SM
    J Nucl Med; 2021 Feb; 62(2):259-265. PubMed ID: 32737247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Inhibition of
    Gresch A; Hurtado HN; Wörmeyer L; De Luca V; Wiggers R; Seebohm G; Wünsch B; Düfer M
    J Pharmacol Exp Ther; 2021 Nov; 379(3):235-244. PubMed ID: 34593560
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.